Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 460

1.

Retrotransposons shuttling genetic and epigenetic information from the nuclear to the mitochondrial compartment: Do they play a pathogenetic role in scleroderma?

Talotta R, Sarzi-Puttini P, Laska MJ, Atzeni F.

Cytokine Growth Factor Rev. 2019 Oct 18. pii: S1359-6101(19)30078-4. doi: 10.1016/j.cytogfr.2019.10.001. [Epub ahead of print] Review.

PMID:
31677967
2.

Cannabinoids in the treatment of rheumatic diseases: Pros and cons.

Sarzi-Puttini P, Ablin J, Trabelsi A, Fitzcharles MA, Marotto D, Häuser W.

Autoimmun Rev. 2019 Dec;18(12):102409. doi: 10.1016/j.autrev.2019.102409. Epub 2019 Oct 21. Review.

PMID:
31648042
3.

Biosimilars vs originators: Are they the same?

Sarzi-Puttini P, Marotto D, Caporali R, Galeazzi M, Atzeni F, Hamar A, Soós B, Szekanecz Z.

Autoimmun Rev. 2019 Dec;18(12):102404. doi: 10.1016/j.autrev.2019.102404. Epub 2019 Oct 19. Review.

PMID:
31639517
4.

Failure of anti-TNF treatment in patients with rheumatoid arthritis: The pros and cons of the early use of alternative biological agents.

Rubbert-Roth A, Szabó MZ, Kedves M, Nagy G, Atzeni F, Sarzi-Puttini P.

Autoimmun Rev. 2019 Dec;18(12):102398. doi: 10.1016/j.autrev.2019.102398. Epub 2019 Oct 19. Review.

PMID:
31639514
5.

Il-6 Involvement in pain, fatigue and mood disorders in rheumatoid arthritis and the effects of Il-6 inhibitor sarilumab.

Atzeni F, Nucera V, Masala IF, Sarzi-Puttini P, Bonitta G.

Pharmacol Res. 2019 Nov;149:104402. doi: 10.1016/j.phrs.2019.104402. Epub 2019 Sep 16. Review.

PMID:
31536783
6.

Medical cannabis and cannabinoids in rheumatology: where are we now?

Sarzi-Puttini P, Batticciotto A, Atzeni F, Bazzichi L, Di Franco M, Salaffi F, Marotto D, Ceribelli A, Ablin JN, Hauser W.

Expert Rev Clin Immunol. 2019 Oct;15(10):1019-1032. doi: 10.1080/1744666X.2019.1665997.

PMID:
31512536
7.

Psoriatic arthritis: From pathogenesis to pharmacologic management.

Talotta R, Atzeni F, Sarzi-Puttini P, Masala IF.

Pharmacol Res. 2019 Oct;148:104394. doi: 10.1016/j.phrs.2019.104394. Epub 2019 Sep 7. Review.

PMID:
31505253
8.

Italian recommendations for influenza and pneumococcal vaccination in adult patients with autoimmune rheumatic diseases.

Guerrini G, Franzetti F, Giacomelli R, Meroni L, Riva A, Scirè CA, Scrivo R, Tavio M, Agostinone A, Airò P, Atzeni F, Bartalesi F, Bazzichi L, Berardicurti O, Cassola G, Castagna A, Castelli F, Cattelan A, Citriniti G, Cristini F, De Rosa F, Fracassi E, Galloway J, La Paglia GMC, Moioli MC, Ripamonti D, Saracino A, Tani C, Tascini C, Tieghi T, Tinelli M, Zabotti A, Sarzi-Puttini P, Galli M.

Clin Exp Rheumatol. 2019 Aug 27. [Epub ahead of print]

PMID:
31498077
9.

Noninvasive imaging methods for evaluating cardiovascular involvement in patients with rheumatoid arthritis before and after anti-TNF drug treatment.

Atzeni F, Gianturco L, Boccassini L, Sarzi-Puttini P, Bonitta G, Turiel M.

Future Sci OA. 2019 Jun 13;5(6):FSO396. doi: 10.2144/fsoa-2018-0108.

10.

The therapeutic journey of biologic agents: There will be an end?

Atzeni F, Sarzi-Puttini P.

Pharmacol Res. 2019 Sep;147:104340. doi: 10.1016/j.phrs.2019.104340. Epub 2019 Jul 2.

PMID:
31276775
11.

Recommendations for managing the manifestations of severe and life-threatening mixed cryoglobulinemia syndrome.

Galli M, Monti G, Marson P, Scaini P, Pietrogrande M, Candela M, Castelnovo L, Faggioli P, Novati P, Zani R, Mascia MT, Saccardo F, Mazzaro C, Sarzi-Puttini P, Sebastiani M, Quartuccio L, De Vita S.

Autoimmun Rev. 2019 Aug;18(8):778-785. doi: 10.1016/j.autrev.2019.06.008. Epub 2019 Jun 8.

PMID:
31181326
12.

Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents.

Atzeni F, Talotta R, Masala IF, Gerardi MC, Casale R, Sarzi-Puttini P.

Best Pract Res Clin Rheumatol. 2018 Aug;32(4):500-510. doi: 10.1016/j.berh.2019.02.003. Epub 2019 Feb 27. Review.

PMID:
31174819
13.

Malar rash is a predictor of subclinical airway inflammation in patients with systemic lupus erythematosus: a pilot study.

Damiani G, Pigatto PDM, Marzano AV, Rizzi M, Santus P, Radovanovic D, Loite U, Torelli L, Petrou S, Sarzi-Puttini P, Atzeni F, Adawi M, Bridgewood C, Bragazzi NL, Watad A, Malerba M.

Clin Rheumatol. 2019 Sep;38(9):2541-2546. doi: 10.1007/s10067-019-04536-y. Epub 2019 Apr 24.

PMID:
31020473
14.

Treatment with golimumab or infliximab reduces health resource utilization and increases work productivity in patients with ankylosing spondylitis in the QUO-VADIS study, a large, prospective real-life cohort.

Claudepierre P, Van den Bosch F, Sarzi-Puttini P, Vastesaeger N, Govoni M, Kachroo S.

Int J Rheum Dis. 2019 Jun;22(6):995-1001. doi: 10.1111/1756-185X.13526. Epub 2019 Apr 15.

PMID:
30989813
15.

Systemic rheumatic diseases: From biological agents to small molecules.

Sarzi-Puttini P, Ceribelli A, Marotto D, Batticciotto A, Atzeni F.

Autoimmun Rev. 2019 Jun;18(6):583-592. doi: 10.1016/j.autrev.2018.12.009. Epub 2019 Apr 5. Review.

PMID:
30959214
16.

Serum klotho concentrations inversely correlate with the severity of nailfold capillaroscopic patterns in patients with systemic sclerosis.

Talotta R, Rigamonti F, Letizia T, Bongiovanni S, Ditto MC, Antivalle M, Santandrea S, Atzeni F, Vago T, Sarzi-Puttini P.

Reumatismo. 2019 Apr 1;71(1):19-23. doi: 10.4081/reumatismo.2019.1129.

17.

Severe bitter taste associated with apremilast.

Damiani G, Bragazzi NL, Grossi E, Petrou S, Radovanovic D, Rizzi M, Atzeni F, Sarzi-Puttini P, Santus P, Pigatto PD, Franchi C.

Dermatol Ther. 2019 May;32(3):e12876. doi: 10.1111/dth.12876. Epub 2019 Mar 26. No abstract available.

PMID:
30882959
18.

Rationale underlying the measurement of fractional exhaled nitric oxide in systemic sclerosis patients.

Rizzi M, Radovanovic D, Airoldi A, Cristiano A, Frassanito F, Gaboardi P, Saad M, Atzeni F, Sarzi-Puttini P, Santus P.

Clin Exp Rheumatol. 2019 Jul-Aug;37 Suppl 119(4):125-132. Epub 2019 Feb 27. Review.

19.

Efficacy and safety data based on historical or pre-existing conditions at baseline for patients with active rheumatoid arthritis who were treated with baricitinib.

Combe B, Balsa A, Sarzi-Puttini P, Tony HP, de la Torre I, Rogai V, Durand F, Witt S, Zhong J, Dougados M.

Ann Rheum Dis. 2019 Aug;78(8):1135-1138. doi: 10.1136/annrheumdis-2018-214261. Epub 2019 Mar 6. No abstract available.

20.

Ultramicronized Palmitoylethanolamide (um-PEA) as Add-on Treatment in Fibromyalgia Syndrome (FMS): Retrospective Observational Study on 407 Patients.

Schweiger V, Martini A, Bellamoli P, Donadello K, Schievano C, Balzo GD, Sarzi-Puttini P, Parolini M, Polati E.

CNS Neurol Disord Drug Targets. 2019;18(4):326-333. doi: 10.2174/1871527318666190227205359.

PMID:
30827269
21.

Response to Wolfe. Letter to the Editor, "Fibromyalgia Criteria".

Arnold LM, Bennett RM, Crofford LJ, Dean LE, Clauw DJ, Goldenberg DL, Fitzcharles MA, Paiva ES, Staud R, Sarzi-Puttini P, Buskila D, Macfarlane GJ.

J Pain. 2019 Jun;20(6):741-742. doi: 10.1016/j.jpain.2019.02.003. Epub 2019 Feb 26. No abstract available.

PMID:
30822536
22.

Brain Modulation by Electric Currents in Fibromyalgia: A Structured Review on Non-invasive Approach With Transcranial Electrical Stimulation.

Brighina F, Curatolo M, Cosentino G, De Tommaso M, Battaglia G, Sarzi-Puttini PC, Guggino G, Fierro B.

Front Hum Neurosci. 2019 Feb 11;13:40. doi: 10.3389/fnhum.2019.00040. eCollection 2019. Review.

23.

Rate of serious infections in spondyloarthropathy patients treated with anti-tumour necrosis factor drugs: a survey from the Italian registry GISEA.

Atzeni F, Sarzi-Puttini P, Sebastiani M, Panetta V, Salaffi F, Iannone F, Carletto A, Foti R, Gremese E, Govoni M, Marchesoni A, Favalli E, Gorla R, Ramonda R, Ferraccioli G, Lapadula G; GISEA group.

Clin Exp Rheumatol. 2019 Jul-Aug;37(4):649-655. Epub 2019 Feb 11.

PMID:
30767865
24.

Neuromuscular efficiency in fibromyalgia is improved by hyperbaric oxygen therapy: looking inside muscles by means of surface electromyography.

Casale R, Boccia G, Symeonidou Z, Atzeni F, Batticciotto A, Salaffi F, Sarzi-Puttini P, Brustio PR, Rainoldi A.

Clin Exp Rheumatol. 2019 Jan-Feb;37 Suppl 116(1):75-80. Epub 2019 Feb 8.

25.

Hyperbaric oxygen treatment of fibromyalgia: a prospective observational clinical study.

Atzeni F, Casale R, Alciati A, Masala IF, Batticciotto A, Talotta R, Gerardi MC, Salaffi F, Sarzi-Puttini P.

Clin Exp Rheumatol. 2019 Jan-Feb;37 Suppl 116(1):63-69. Epub 2019 Feb 6.

PMID:
30747099
26.

Fibromyalgia and the concept of resilience.

Casale R, Sarzi-Puttini P, Botto R, Alciati A, Batticciotto A, Marotto D, Torta R.

Clin Exp Rheumatol. 2019 Jan-Feb;37 Suppl 116(1):105-113. Epub 2019 Feb 8. Review.

PMID:
30747098
27.

Fibromyalgia syndrome: under-, over- and misdiagnosis.

Häuser W, Sarzi-Puttini P, Fitzcharles MA.

Clin Exp Rheumatol. 2019 Jan-Feb;37 Suppl 116(1):90-97. Epub 2019 Feb 8. Review.

28.

T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy.

Guggino G, Schinocca C, Lo Pizzo M, Di Liberto D, Garbo D, Raimondo S, Alessandro R, Brighina F, Ruscitti P, Giacomelli R, Sireci G, Triolo G, Casale R, Sarzi-Puttini P, Dieli F.

Clin Exp Rheumatol. 2019 Jan-Feb;37 Suppl 116(1):81-89. Epub 2019 Feb 8.

PMID:
30747094
29.

Microbial Agents as Putative Inducers of B Cell Lymphoma in Sjögren's Syndrome through an Impaired Epigenetic Control: The State-of-The-Art.

Talotta R, Sarzi-Puttini P, Atzeni F.

J Immunol Res. 2019 Jan 6;2019:8567364. doi: 10.1155/2019/8567364. eCollection 2019. Review.

30.

Evaluation of salivary and plasma microRNA expression in patients with Sjögren's syndrome, and correlations with clinical and ultrasonographic outcomes.

Talotta R, Mercurio V, Bongiovanni S, Vittori C, Boccassini L, Rigamonti F, Batticciotto A, Atzeni F, Trabattoni D, Sarzi-Puttini P, Biasin M.

Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):70-77. Epub 2019 Jan 10.

31.

Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis.

Sebastiani M, Milazzo L, Atzeni F, Vacchi C, Manfredi A, Quartuccio L, Scirè C, Gaeta GB, Lapadula G, Armignacco O, Tavio M, D'Angelo S, Meroni P, Bazzichi L, Grassi W, Mathieu A, Mastroianni C, Sagnelli E, Santantonio T, Foppa CU, Puoti M, Sarmati L, Airò P, Epis OM, Scrivo R, Gargiulo M, Riva A, Ciancio G, Zehender G, Taliani G, Meroni L, Sollima S, Sarzi-Puttini P, Galli M.

Mod Rheumatol. 2019 Nov;29(6):895-902. doi: 10.1080/14397595.2018.1558918. Epub 2019 Jan 22. Erratum in: Mod Rheumatol. 2019 Apr 2;:1.

PMID:
30582388
32.

AAPT Diagnostic Criteria for Fibromyalgia.

Arnold LM, Bennett RM, Crofford LJ, Dean LE, Clauw DJ, Goldenberg DL, Fitzcharles MA, Paiva ES, Staud R, Sarzi-Puttini P, Buskila D, Macfarlane GJ.

J Pain. 2019 Jun;20(6):611-628. doi: 10.1016/j.jpain.2018.10.008. Epub 2018 Nov 16. Review.

33.

Patients', physicians', nurses', and pharmacists' preferences on the characteristics of biologic agents used in the treatment of rheumatic diseases.

Scalone L, Sarzi-Puttini P, Sinigaglia L, Montecucco C, Giacomelli R, Lapadula G, Olivieri I, Giardino AM, Cortesi PA, Mantovani LG, Mecchia M.

Patient Prefer Adherence. 2018 Oct 16;12:2153-2168. doi: 10.2147/PPA.S168458. eCollection 2018.

34.

The influence of comorbidities on the efficacy of tumour necrosis factor inhibitors, and the effect of tumour necrosis factor inhibitors on comorbidities in rheumatoid arthritis: report from a National Consensus Conference.

Conti F, Atzeni F, Massaro L, Chiara Gerardi M, Gremese E, Passiu G, Carletto A, Malavolta N, Foti R, Ramonda R, Sarzi-Puttini P.

Rheumatology (Oxford). 2018 Oct 1;57(57 Suppl 7):vii11-vii22. doi: 10.1093/rheumatology/key209. Review.

PMID:
30289537
35.

Usefulness of six-minute walk test in systemic sclerosis.

Rizzi M, Radovanovic D, Santus P, Airoldi A, Frassanito F, Vanni S, Cristiano A, Sarzi-Puttini P, Atzeni F.

Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):161-167. Epub 2018 Sep 7. Review.

PMID:
30277863
36.

Epidemiological, pharmacological and sociodemographic characterisation of a population of 386 fibromyalgic patients referred to a tertiary pain centre in Italy.

Martini A, Schweiger V, Del Balzo G, Sartori G, Parolini M, Chinellato E, Sarzi-Puttini P, Polati E.

Clin Exp Rheumatol. 2019 Jan-Feb;37 Suppl 116(1):27-38. Epub 2018 Aug 29.

PMID:
30183596
37.

Controlled-release pregabalin in the treatment of fibromyalgia.

Alciati A, Atzeni F, Masala IF, Cirillo M, Sciortino D, Perna G, Sarzi-Puttini P.

Expert Rev Neurother. 2018 Aug;18(8):617-623. doi: 10.1080/14737175.2018.1508344. Epub 2018 Aug 23. Review.

PMID:
30092164
38.

The Effect of Neuropathic Pain Symptoms on Remission in Patients with Early Rheumatoid Arthritis.

Salaffi F, Di Carlo M, Carotti M, Sarzi-Puttini P.

Curr Rheumatol Rev. 2019;15(2):154-161. doi: 10.2174/1573397114666180806142814.

PMID:
30081788
39.

Adverse events, clinical considerations and management recommendations in rheumatoid arthritis patients treated with JAK inhibitors.

Atzeni F, Talotta R, Nucera V, Marino F, Gerratana E, Sangari D, Masala IF, Sarzi-Puttini P.

Expert Rev Clin Immunol. 2018 Nov;14(11):945-956. doi: 10.1080/1744666X.2018.1504678. Epub 2018 Aug 21. Review. Erratum in: Expert Rev Clin Immunol. 2018 Nov;14(11):ix.

PMID:
30058434
40.

Clinical, Ultrasound, and Predictability Outcomes Following Certolizumab Pegol Treatment (with Methotrexate) in Patients with Moderate-to-Severe Rheumatoid Arthritis: 52-Week Results from the CZP-SPEED Study.

Sarzi-Puttini P, Filippucci E, Adami S, Meroni PL, Batticciotto A, Idolazzi L, De Lucia O, Talavera P, Kumke T, Grassi W.

Adv Ther. 2018 Aug;35(8):1153-1168. doi: 10.1007/s12325-018-0751-8. Epub 2018 Jul 24.

41.

From autoinflammation to autoimmunity: old and recent findings.

Caso F, Costa L, Nucera V, Barilaro G, Masala IF, Talotta R, Caso P, Scarpa R, Sarzi-Puttini P, Atzeni F.

Clin Rheumatol. 2018 Sep;37(9):2305-2321. doi: 10.1007/s10067-018-4209-9. Epub 2018 Jul 16. Review.

PMID:
30014358
42.

The subjective components of the Disease Activity Score 28-joints (DAS28) in rheumatoid arthritis patients and coexisting fibromyalgia.

Salaffi F, Di Carlo M, Carotti M, Sarzi-Puttini P.

Rheumatol Int. 2018 Oct;38(10):1911-1918. doi: 10.1007/s00296-018-4096-z. Epub 2018 Jun 28.

PMID:
29955927
43.

A Review of Chronic Musculoskeletal Pain: Central and Peripheral Effects of Diclofenac.

Atzeni F, Masala IF, Sarzi-Puttini P.

Pain Ther. 2018 Dec;7(2):163-177. doi: 10.1007/s40122-018-0100-2. Epub 2018 Jun 5. Review.

44.

Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series.

Talotta R, Atzeni F, Batticciotto A, Ditto MC, Gerardi MC, Sarzi-Puttini P.

J Med Case Rep. 2018 Jun 3;12(1):154. doi: 10.1186/s13256-018-1687-y.

45.

Neurobiological similarities between RA and fibromyalgia.

Atzeni F, Sarzi-Puttini P.

Nat Rev Rheumatol. 2018 Jun;14(6):324-325. doi: 10.1038/s41584-018-0011-y. No abstract available.

PMID:
29765137
46.

Cardiovascular Imaging Techniques in Systemic Rheumatic Diseases.

Atzeni F, Corda M, Gianturco L, Porcu M, Sarzi-Puttini P, Turiel M.

Front Med (Lausanne). 2018 Feb 14;5:26. doi: 10.3389/fmed.2018.00026. eCollection 2018. Review.

47.

Ankylosing Spondylitis Treatment after First Anti-TNF Drug Failure.

Benucci M, Damiani A, Bandinelli F, Grossi V, Infantino M, Manfredi M, Gobbi FL, Sarzi-Puttini P, Atzeni F.

Isr Med Assoc J. 2018 Feb;20(2):119-122. Review. No abstract available.

48.

The role of klotho in systemic sclerosis.

Talotta R, Bongiovanni S, Letizia T, Rigamonti F, Atzeni F, Benucci M, Vago T, Sarzi-Puttini P.

Reumatismo. 2017 Dec 21;69(4):156-163. doi: 10.4081/reumatismo.2017.987.

49.

An update on emerging drugs for fibromyalgia treatment.

Atzeni F, Gerardi MC, Masala IF, Alciati A, Batticciotto A, Sarzi-Puttini P.

Expert Opin Emerg Drugs. 2017 Dec;22(4):357-367. doi: 10.1080/14728214.2017.1418323. Epub 2017 Dec 19. Review.

PMID:
29250975
50.

Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review.

Atzeni F, Gerardi MC, Barilaro G, Masala IF, Benucci M, Sarzi-Puttini P.

Expert Rev Clin Immunol. 2018 Jan;14(1):69-82. doi: 10.1080/1744666X.2018.1411190. Epub 2017 Dec 11. Review.

PMID:
29202589

Supplemental Content

Loading ...
Support Center